Zhejiang Benli Technology Co. Ltd. (301065) - Total Liabilities

Latest as of March 2026: CN¥241.20 Million CNY ≈ $35.30 Million USD

Based on the latest financial reports, Zhejiang Benli Technology Co. Ltd. (301065) has total liabilities worth CN¥241.20 Million CNY (≈ $35.30 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Zhejiang Benli Technology Co. Ltd. - Total Liabilities Trend (2019–2025)

This chart illustrates how Zhejiang Benli Technology Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. See Zhejiang Benli Technology Co. Ltd. working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Zhejiang Benli Technology Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of Zhejiang Benli Technology Co. Ltd. ranked by their total liabilities.

Company Country Total Liabilities
Fujian Jinsen Forestry Co Ltd
SHE:002679
China CN¥1.19 Billion
Xinjiang Hejin Holding Co Ltd
SHE:000633
China CN¥102.50 Million
DB Financial Investment Co Ltd
KO:016610
Korea ₩13.00 Trillion
Weifu High Tech Group
SHE:200581
China HK$8.98 Billion
HLE Glascoat Limited
NSE:HLEGLAS
India Rs7.64 Billion
Ajmera Realty & Infra India Limited
NSE:AJMERA
India Rs9.43 Billion
Hudaco
JSE:HDC
South Africa ZAC2.83 Billion
Broedrene A&O Johansen A/S Series B
CO:AOJ-B
Denmark Dkr2.66 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down Zhejiang Benli Technology Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zhejiang Benli Technology Co. Ltd. (301065) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.54 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.17 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang Benli Technology Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang Benli Technology Co. Ltd. (2019–2025)

The table below shows the annual total liabilities of Zhejiang Benli Technology Co. Ltd. from 2019 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥279.13 Million
≈ $40.85 Million
-12.05%
2024-12-31 CN¥317.36 Million
≈ $46.44 Million
+62.66%
2023-12-31 CN¥195.10 Million
≈ $28.55 Million
+32.24%
2022-12-31 CN¥147.54 Million
≈ $21.59 Million
+1.83%
2021-12-31 CN¥144.89 Million
≈ $21.20 Million
-13.57%
2020-12-31 CN¥167.63 Million
≈ $24.53 Million
+5.78%
2019-12-31 CN¥158.47 Million
≈ $23.19 Million
--

About Zhejiang Benli Technology Co. Ltd.

SHE:301065 China Chemicals
Market Cap
$290.58 Million
CN¥1.99 Billion CNY
Market Cap Rank
#15085 Global
#4465 in China
Share Price
CN¥18.73
Change (1 day)
-1.89%
52-Week Range
CN¥18.73 - CN¥25.99
All Time High
CN¥51.11
About

Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sales of pharmaceutical, pesticide, and new material intermediates in China and internationally. Its products include 2,4-Dichloro-5-fluorobenzoyl chloride, 2-(2,4-Dichloro-5-fluorobenzoyl)-3-cyclopropylamine ethyl acrylate, 1-Ethyl-7-(1-piperazinyl) -6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid hy… Read more